
Explore the key conclusions around aiming for higher treatment targets, discussed at the UCB-sponsored Satellite Symposium presented at EULAR 2023.
Dr Elena Nikiphorou is a consultant rheumatologist at King’s College Hospital, London, UK, and an adjunct senior lecturer at King’s College London, UK.
Dr Nikiphorou has a clinical and academic interest in inflammatory arthritis, multi-morbidity and long-term outcomes of disease. She has been the recipient of multiple national and international awards, bursaries and competitive roles. She has been involved in the development of several international recommendations, including on the management of difficult-to-treat rheumatoid arthritis, axial spondyloarthritis and self-management strategies in inflammatory arthritis.
Watch Prof Frank Behrens discuss the importance of treating skin symptoms in addition to musculoskeletal symptoms for patients with SpA.
Achieving ACR50 is associated with improvements in quality of life for patients with PsA.1 Dive into the data supporting higher treatment targets in clinical...
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss how MDA is a realistic treatment target in clinical practice and the barriers to achieving it for...
Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof Philipp Sewerin explain how MDA can...
Explore the key conclusions around aiming for higher treatment targets, discussed at the UCB-sponsored Satellite Symposium presented at EULAR 2023.
axSpA is a complex disease with a significant burden on many aspects of daily life.1,2 Dive into the importance of ASAS40 for your patients with Dr Fabian Proft.